NovoCure (NVCR) EBIT (2014 - 2026)
NovoCure (NVCR) posted quarterly EBIT of -$10.6 million for Q2 2026, up 73.27% year-on-year from -$6.1 million in Q2 2025, and up 84.33% on a QoQ basis from -$67.4 million in Q1 2026.
NovoCure (NVCR) EBIT (2014 - 2026) Analysis & Trends
NovoCure (NVCR) has reported EBIT for 13 consecutive years, with -$10.6 million the latest figure, recorded in Q2 2026.
- Quarterly EBIT rose 73.27% year-over-year to -$10.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$154.4 million (up 10.64% YoY) and the FY2025 annual result came in at -$153.8 million, up 9.79% from the prior year.
- EBIT grew to -$10.6 million in Q2 2026 per NVCR's latest filing, from -$67.4 million in the prior quarter.
- Over the last five years, EBIT for NVCR reached as high as -$806000.0 in Q1 2022 and fell as low as -$67.4 million in Q1 2026.
- A 5-year average of -$40.3 million and a median of -$40.0 million in 2025 frame the typical range for EBIT.
- Annual changes were most pronounced in 2023 — EBIT sank 7375.06% — and 2026, when it soared 73.27%.
- Year by year, EBIT stood at -$43.0 million in 2022, then decreased by 20.33% to -$51.7 million in 2023, then decreased by 22.41% to -$63.3 million in 2024, then surged by 36.19% to -$40.4 million in 2025, then jumped by 73.85% to -$10.6 million in 2026.
- According to Business Quant data, EBIT over the past three periods registered -$10.6 million, -$67.4 million, and -$40.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NovoCure | 2.28 Bn | 1.85 Bn | 142.48 Mn | -10.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.56 Mn |
| Mar 31, 2026 | -67.42 Mn |
| Dec 31, 2025 | -40.39 Mn |
| Sep 30, 2025 | -36.02 Mn |
| Jun 30, 2025 | -39.52 Mn |
| Mar 31, 2025 | -37.87 Mn |
| Dec 31, 2024 | -63.30 Mn |
| Sep 30, 2024 | -32.09 Mn |
| Jun 30, 2024 | -33.58 Mn |
| Mar 31, 2024 | -41.52 Mn |
| Dec 31, 2023 | -51.72 Mn |
| Sep 30, 2023 | -58.25 Mn |
| Jun 30, 2023 | -62.66 Mn |
| Mar 31, 2023 | -60.25 Mn |
| Dec 31, 2022 | -42.98 Mn |
| Sep 30, 2022 | -24.61 Mn |
| Jun 30, 2022 | -21.13 Mn |
| Mar 31, 2022 | -806,000.00 |
| Dec 31, 2021 | -23.40 Mn |
| Sep 30, 2021 | -8.55 Mn |